CSPC Pharmaceutical Group Ltd. | Mutual Funds
Mutual Funds that own CSPC Pharmaceutical Group Ltd.
First State Global Umbrella Fd. Plc - China Growth Fund
103,632,000
1.66%
-4,776,000
6.02%
09/30/2017
Government Pension Fund - Global (The)
93,085,989
1.49%
-10,224,304
0.03%
12/31/2017
Vanguard Emerging Markets Stock Index Fund
67,588,732
1.08%
-560,000
0.21%
07/31/2018
Vanguard Total International Stock Index Fund
62,115,084
1%
952,000
0.04%
07/31/2018
iShares Core MSCI Emerging Markets ETF
39,314,000
0.63%
0
0.2%
09/05/2018
UBS (Lux) Equity Fund - China Opportunity
35,536,000
0.56%
0
2.39%
01/31/2018
Investec Global Strategy Fund - Asian Equity Fund
34,238,000
0.55%
-1,800,000
1.67%
06/30/2018
Baron Emerging Markets Fund
28,733,617
0.46%
1,183,676
1.39%
06/30/2018
iShares MSCI Emerging Markets ETF
27,920,000
0.45%
0
0.22%
09/06/2018
Hang Seng Index ETF
26,973,024
0.43%
26,515,472
1.04%
06/29/2018
| Address |
Suite 3206, 32nd Floor
Hong Kong
Hong Kong
|
|
Employees
|
- |
| Website |
http://www.cspc.com.hk |
| Updated |
07/08/2019 |
| CSPC Pharmaceutical Group Ltd. is an investment holding company, which is engaged in the manufacturing and selling of pharmaceutical products. It operates through the following business segments: Finished Drugs, Antibiotics, Vitamin C, Caffeine and Others. The company was founded on August 21, 1997 and is headquartered in Hong Kong. |
